Case Studies

Design and Development of a qPCR Mastermix

Biofortuna have recently provided a bespoke qPCR mastermix to be used with hydrolysis probes as part of a complex genotyping kit. The mastermix was designed under Biofortuna’s ISO:13485 and FDA quality system. The mastermix will be used as part of an IVD kit which has undergone a global launch.

Design and Development of qPCR Assays

Biofortuna have recently completed the design and development of a set of 384 multiplex genotyping Taqman-based PCR reactions.

Lyophilisation of LAMP-based Diagnostic Kit

A diagnostics company looking for a contract services provider have used Biofortuna to launch their first CE marked, lyophilised LAMP based kit onto the market. This kit will be used for the direct detection of meningococcus and significantly reduces set up times from current preferred methodologies.

Dispensing and Kitting of NGS kits

A  Next-Generation Sequencing company was looking for a partner to outsource the dispensing and kitting of their CE-marked kit.

Contract Immunoassay R&D for Early Cancer Detection Company

Biofortuna have signed a long-term contract to provide contract research and development to a leading early cancer detection company. This relationship will lead to the commercialisation of  an ELISA based oncology assay.

| Next Page